We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+18.63%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$607M
AUM Growth
–
Cap. Flow
+$583M
Cap. Flow
% of AUM
96.07%
Top 10 Holdings %
Top 10 Hldgs %
4.88%
Holding
1,467
New
1,467
Increased
–
Reduced
–
Closed
–
Top Buys
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.29% |
| 2 | Consumer Discretionary | 1.08% |
| 3 | Technology | 1.07% |
| 4 | Industrials | 0.79% |
| 5 | Financials | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
AbbVie
ABBV
$454B
| $3.72M | 0.61% |
+46,200
| New | +$3.78M |
|
2
CALL
AT&T
T
$157B
| $3.34M | 0.55% |
+140,874
| New | +$3.24M |
|
3
CALL
Merck
MRK
$322B
| $3.18M | 0.52% |
+40,034
| New | +$2.99M |
|
4
CALL
Trade Desk
TTD
$7.89B
| $3.07M | 0.51% |
+155,000
| New | +$2.54M |
|
|
SHLL.U
5
DELISTED
Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half
SHLL.U
| $3M | 0.49% |
+300,000
| New | +$3M |
|
6
CALL
Oracle
ORCL
$346B
| $2.87M | 0.47% |
+53,500
| New | +$2.73M |
|
7
CALL
Regeneron Pharmaceuticals
REGN
$68.3B
| $2.67M | 0.44% |
+6,500
| New | +$2.68M |
|
8
CALL
Estee Lauder
EL
$28.9B
| $2.65M | 0.44% |
+16,000
| New | +$2.35M |
|
|
COUP
9
CALL
DELISTED
Coupa Software Incorporated
COUP
| $2.61M | 0.43% |
+28,700
| New | +$2.46M |
|
10
CALL
Thermo Fisher Scientific
TMO
$213B
| $2.55M | 0.42% |
+9,300
| New | +$2.31M |
|
|
JFKKU
11
DELISTED
8i Enterprises Acquisition Corp Unit
JFKKU
| $2.51M | 0.41% |
+250,000
| New | +$2.51M |
|
12
CALL
Revvity
RVTY
$12.6B
| $2.5M | 0.41% |
+26,000
| New | +$2.34M |
|
13
CALL
FedEx
FDX
$74.7B
| $2.5M | 0.41% |
+13,800
| New | +$2.44M |
|
14
CALL
Check Point Software Technologies
CHKP
$12.9B
| $2.49M | 0.41% |
+19,700
| New | +$2.29M |
|
15
CALL
MongoDB
MDB
$24.1B
| $2.48M | 0.41% |
+16,900
| New | +$1.73M |
|
16
CALL
ANI Pharmaceuticals
ANIP
$1.79B
| $2.46M | 0.4% |
+34,800
| New | +$2.05M |
|
17
CALL
Sempra
SRE
$61.1B
| $2.45M | 0.4% |
+39,000
| New | +$2.3M |
|
18
PUT
Incyte
INCY
$23.3B
| $2.4M | 0.4% |
+27,900
| New | +$2.27M |
|
19
CALL
Gilead Sciences
GILD
$162B
| $2.39M | 0.39% |
+36,800
| New | +$2.45M |
|
20
CALL
Autodesk
ADSK
$43.3B
| $2.35M | 0.39% |
+15,100
| New | +$2.26M |
|
21
CALL
Credit Acceptance
CACC
$6.2B
| $2.35M | 0.39% |
+5,200
| New | +$2.24M |
|
22
CALL
Visa
V
$669B
| $2.31M | 0.38% |
+14,800
| New | +$2.13M |
|
23
CALL
Meta Platforms (Facebook)
META
$1.54T
| $2.3M | 0.38% |
+13,800
| New | +$2.19M |
|
24
CALL
Carvana
CVNA
$43.1B
| $2.29M | 0.38% |
+197,000
| New | +$1.66M |
|
25
CALL
Palo Alto Networks
PANW
$265B
| $2.28M | 0.38% |
+56,400
| New | +$2.09M |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q1 2019 Portfolio in Review
Q1 2019 is the first quarter with a 13F filing on record for Walleye Capital, which disclosed 1,467 positions worth $607M. Its ten largest holdings account for 4.9% of the portfolio.
Its largest position is Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half: 300,000 shares worth $3M.
By sector, the portfolio is most concentrated in Healthcare at 1.3% of assets, followed by Consumer Discretionary and Technology.
- Walleye Capital's largest Q1 2019 buy was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half: 300,000 shares worth $3M.
- Walleye Capital's ten largest holdings make up 4.9% of its $607M portfolio in Q1 2019.
- Walleye Capital disclosed 1,467 positions in Q1 2019, its first 13F filing on record.
Based on Walleye Capital's 13F filing for Q1 2019, filed 15 May 2019.